These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35186711)

  • 1. The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy.
    Saigusa N; Hirai H; Tada Y; Kawakita D; Nakaguro M; Tsukahara K; Kano S; Ozawa H; Kondo T; Okami K; Togashi T; Sato Y; Urano M; Kajiwara M; Shimura T; Fushimi C; Shimizu A; Okamoto I; Okada T; Suzuki T; Imanishi Y; Watanabe Y; Sakai A; Ebisumoto K; Sato Y; Honma Y; Yamazaki K; Ueki Y; Hanazawa T; Saito Y; Takahashi H; Ando M; Kohsaka S; Matsuki T; Nagao T
    Front Oncol; 2021; 11():779882. PubMed ID: 35186711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.
    Mayer M; Wolber P; Prinz J; Jansen L; Esser J; Shabli S; Quaas A; Klußmann JP; Sharma SJ; Nachtsheim L; Arolt C
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3779-3789. PubMed ID: 38587651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.
    Takase S; Kano S; Tada Y; Kawakita D; Shimura T; Hirai H; Tsukahara K; Shimizu A; Imanishi Y; Ozawa H; Okami K; Sato Y; Sato Y; Fushimi C; Okada T; Sato H; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Hanazawa T; Chazono H; Osamura RY; Nagao T
    Oncotarget; 2017 Aug; 8(35):59023-59035. PubMed ID: 28938615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma.
    Hirai H; Tada Y; Nakaguro M; Kawakita D; Sato Y; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Okamoto I; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Saigusa N; Takahashi H; Ando M; Urano M; Hanazawa T; Nagao T
    Virchows Arch; 2020 Aug; 477(2):291-299. PubMed ID: 32103349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade.
    Lassche G; Tada Y; van Herpen CML; Jonker MA; Nagao T; Saotome T; Hirai H; Saigusa N; Takahashi H; Ojiri H; van Engen-Van Grunsven ACH; Schalken JA; Fushimi C; Verhaegh GW
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.
    Kawakita D; Nagao T; Takahashi H; Kano S; Honma Y; Hirai H; Saigusa N; Akazawa K; Tani K; Ojiri H; Tsukahara K; Ozawa H; Okami K; Kondo T; Togashi T; Fushimi C; Shimura T; Shimizu A; Okamoto I; Okada T; Imanishi Y; Watanabe Y; Otsuka K; Sakai A; Ebisumoto K; Sato Y; Yamazaki K; Ueki Y; Hanazawa T; Saito Y; Ando M; Matsuki T; Nakaguro M; Sato Y; Urano M; Utsumi Y; Kohsaka S; Saotome T; Tada Y
    Ther Adv Med Oncol; 2022; 14():17588359221119538. PubMed ID: 36090801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma.
    Liang L; Williams MD; Bell D
    Head Neck Pathol; 2019 Dec; 13(4):529-534. PubMed ID: 30390196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
    Gargano SM; Senarathne W; Feldman R; Florento E; Stafford P; Swensen J; Vranic S; Gatalica Z
    Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
    Masubuchi T; Tada Y; Maruya S; Osamura Y; Kamata SE; Miura K; Fushimi C; Takahashi H; Kawakita D; Kishimoto S; Nagao T
    Int J Clin Oncol; 2015 Feb; 20(1):35-44. PubMed ID: 24553861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
    Xu B; Dogan S; Haroon Al Rasheed MR; Ghossein R; Katabi N
    Hum Pathol; 2019 Nov; 93():30-36. PubMed ID: 31430492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ; Koh YW; Yoon SO
    Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.
    Urano M; Hirai H; Tada Y; Kawakita D; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Sato Y; Saigusa N; Nakaguro M; Hanazawa T; Nagao T
    Histopathology; 2018 Dec; 73(6):943-952. PubMed ID: 29993139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival analysis and immunohistochemical study of HER-2 and AR (androgen receptor) expression in salivary duct carcinoma].
    Otsuka K; Imanishi Y; Habu N; Sato Y; Shigetomi S; Fujii R; Sakamoto K; Tomita T; Fujii M; Kameyama K; Ogawa K
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Sep; 116(9):1024-32. PubMed ID: 24191589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report.
    Yang ZY; Huang JH; Chen B; Xu CW; Lei L; Wang XJ; Fang MY
    Front Oncol; 2020; 10():559057. PubMed ID: 33123470
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas.
    Yang RK; Zhao P; Lu C; Luo J; Hu R
    Hum Pathol; 2019 Feb; 84():173-182. PubMed ID: 30267779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy.
    McAfee JL; Hoda RS; Hoyle C; McCoy L; Sprague C; Reddy CA; Koyfman SA; Geiger JL; Komforti MK; Griffith CC
    Mod Pathol; 2023 Oct; 36(10):100273. PubMed ID: 37423585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma.
    Suzuki T; Kano S; Suzuki M; Yasukawa S; Mizumachi T; Tsushima N; Hatanaka KC; Hatanaka Y; Matsuno Y; Homma A
    Front Oncol; 2020; 10():603717. PubMed ID: 33692941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.
    Jeong JS; Cho KJ; Kim D; Lee YS; Song JS
    Pathol Res Pract; 2021 Dec; 228():153678. PubMed ID: 34781210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma.
    van Boxtel W; Locati LD; van Engen-van Grunsven ACH; Bergamini C; Jonker MA; Fiets E; Cavalieri S; Tooten S; Bos E; Quattrone P; Verhaegh GW; Schalken JA; Licitra L; van Herpen CML;
    Eur J Cancer; 2019 Mar; 110():62-70. PubMed ID: 30771738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.